Yayın:
Design, Synthesis, and Evaluation of a New Series of Hydrazones as Small-Molecule Akt Inhibitors for NSCLC Therapy

Sadeleştirilmiş öğe sayfası
dc.contributor.authorErdönmez, Burak
dc.contributor.authorÇiftçi, Gülşen Akalın
dc.contributor.authorALTINTOP, MEHLİKA DİLEK
dc.contributor.authorÖZDEMİR, AHMET
dc.contributor.authorAbdulilah Ece
dc.contributor.orcid0000-0002-8159-663X
dc.contributor.orcid0000-0001-5098-8967
dc.contributor.orcid0000-0003-0280-5550
dc.contributor.orcid0000-0002-3087-5145
dc.date.accessioned2025-11-13T10:26:18Z
dc.date.issued2023-05-24
dc.identifier.doihttps://doi.org/10.1021/acsomega.3c02331
dc.identifier.endpage20065
dc.identifier.issn2470-1343
dc.identifier.issue22
dc.identifier.openalexW4377982412
dc.identifier.startpage20056
dc.identifier.urihttps://hdl.handle.net/11421/4148
dc.identifier.urihttps://doi.org/10.1021/acsomega.3c02331
dc.identifier.volume8
dc.language.isoen
dc.relation.ispartofACS Omega
dc.rightsopenAccess
dc.subjectProtein kinase B
dc.subjectA549 cell
dc.subjectChemistry
dc.subjectApoptosis
dc.subjectCytotoxic T cell
dc.subjectIn vitro
dc.subjectCell culture
dc.subjectPI3K/AKT/mTOR pathway
dc.subjectCancer research
dc.subjectStereochemistry
dc.subjectPharmacology
dc.subjectBiochemistry
dc.subjectBiology
dc.subjectGenetics
dc.subject.sdg3
dc.titleDesign, Synthesis, and Evaluation of a New Series of Hydrazones as Small-Molecule Akt Inhibitors for NSCLC Therapy
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5092009614
local.authorid.openalexA5045943806
local.authorid.openalexA5048968214
local.authorid.openalexA5100651829

Dosyalar

Koleksiyonlar

Publications